Literature DB >> 16340720

18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in-vitro comparison with other PET tracers.

Anne Rixt Buursma1, Vera Rutgers, Geke A P Hospers, Nanno H Mulder, Willem Vaalburg, Erik F J de Vries.   

Abstract

OBJECTIVE: The herpes simplex virus thymidine kinase (HSVtk) gene has frequently been applied as a reporter gene for monitoring transgene expression in animal models. In clinical gene therapy protocols, however, extremely low expression levels of the transferred gene are generally observed. Consequently, sensitive and selective radiotracers for imaging are required. This study describes the in-vitro evaluation of 2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil (18F-FEAU) as a candidate tracer for HSVtk imaging with positron emission tomography (PET).
METHODS: In cellular accumulation experiments, the potential of 18F-FEAU as a PET tracer for HSVtk was compared to the known acyclic guanosine derivatives 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine (18F-FHPG) and 9-[4-[18F]fluoro-3-(hydroxymethyl)butyl]guanine (18F-FHBG), and the thymidine derivatives 3'-deoxy-3'-[18F]fluorothymidine (18F-FLT), 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) and 2'-deoxy-2'-[18F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil (18F-FIAU). For this purpose, C6 control cells and HSVtk-expressing C6tk cells were incubated with the different tracers for various periods of time and cellular uptake and initial uptake rates were analysed. The initial rate of tracer uptake was determined from the slope of the plot of tracer uptake versus incubation time.
RESULTS: After 2 h of tracer incubation, the C6tk/C6 accumulation ratio was 1.6 for 18F-FLT, 2.4 for F-FMAU, 5.5 for 18F-FHPG, 10.3 for 18F-FIAU, 40.8 for 18F-FHBG and 84.5 for 18F-FEAU. The initial tracer uptake rate in C6tk cells was in the order FLT>FMAU>FEAU>FIAU>FHBG>FHPG, whereas the initial tracer uptake rate in C6 control cells was FLT>FMAU>FIAU>FEAU approximately = FHBG approximately = FHPG. The highest HSVtk specific uptake was observed for FEAU.
CONCLUSION: This study indicates that the high uptake rate of FEAU together with its high selectivity make this tracer an excellent candidate as a PET tracer for HSVtk gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16340720     DOI: 10.1097/01.mnm.0000186609.12895.20

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  11 in total

1.  An improved strategy for the synthesis of [¹⁸F]-labeled arabinofuranosyl nucleosides.

Authors:  Hanwen Zhang; Melchor V Cantorias; NagaVaraKishore Pillarsetty; Eva M Burnazi; Shangde Cai; Jason S Lewis
Journal:  Nucl Med Biol       Date:  2012-07-18       Impact factor: 2.408

2.  Establishing the Lysine-rich Protein CEST Reporter Gene as a CEST MR Imaging Detector for Oncolytic Virotherapy.

Authors:  Christian T Farrar; Jason S Buhrman; Guanshu Liu; Anne Kleijn; Martine L M Lamfers; Michael T McMahon; Assaf A Gilad; Giulia Fulci
Journal:  Radiology       Date:  2015-02-13       Impact factor: 11.105

3.  PET imaging of oncolytic VSV expressing the mutant HSV-1 thymidine kinase transgene in a preclinical HCC rat model.

Authors:  Kim A Muñoz-Álvarez; Jennifer Altomonte; Iina Laitinen; Sibylle Ziegler; Katja Steiger; Irene Esposito; Roland M Schmid; Oliver Ebert
Journal:  Mol Ther       Date:  2015-01-22       Impact factor: 11.454

4.  5-[18F]Fluoroalkyl pyrimidine nucleosides: probes for positron emission tomography imaging of herpes simplex virus type 1 thymidine kinase gene expression.

Authors:  Ann-Marie Chacko; Eric Blankemeyer; Brian P Lieberman; Wenchao Qu; Hank F Kung
Journal:  Nucl Med Biol       Date:  2009-01       Impact factor: 2.408

5.  Semiautomated radiosynthesis and biological evaluation of [18F]FEAU: a novel PET imaging agent for HSV1-tk/sr39tk reporter gene expression.

Authors:  Frederick T Chin; Mohammed Namavari; Jelena Levi; Murugesan Subbarayan; Pritha Ray; Xiaoyuan Chen; Sanjiv S Gambhir
Journal:  Mol Imaging Biol       Date:  2007-12-22       Impact factor: 3.488

6.  In Vivo Cellular Imaging for Translational Medical Research.

Authors:  Ali S Arbab; Branislava Janic; Jodi Haller; Edyta Pawelczyk; Wei Liu; Joseph A Frank
Journal:  Curr Med Imaging Rev       Date:  2009-02-01

7.  Noninvasive imaging of cell-mediated therapy for treatment of cancer.

Authors:  Elizabeth J Akins; Purnima Dubey
Journal:  J Nucl Med       Date:  2008-06       Impact factor: 10.057

8.  Evaluation of herpes simplex virus 1 thymidine kinase-mediated trapping of (131)I FIAU and prodrug activation of ganciclovir as a synergistic cancer radio/chemotherapy.

Authors:  Meike L Schipper; Michael L Goris; Sanjiv S Gambhir
Journal:  Mol Imaging Biol       Date:  2007 May-Jun       Impact factor: 3.484

9.  Endothelial progenitor cells (EPCs) as gene carrier system for rat model of human glioma.

Authors:  Nadimpalli Ravi S Varma; Branislava Janic; A S M Iskander; Adarsh Shankar; Mohammed P I Bhuiyan; Hamid Soltanian-Zadeh; Quan Jiang; Kenneth Barton; Meser M Ali; Ali S Arbab
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

10.  Imaging grafted cells with [18F]FHBG using an optimized HSV1-TK mammalian expression vector in a brain injury rodent model.

Authors:  Anne-Sophie Salabert; Laurence Vaysse; Marie Beaurain; Mathieu Alonso; Germain Arribarat; Jean-Albert Lotterie; Isabelle Loubinoux; Mathieu Tafani; Pierre Payoux
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.